Cargando…
Superselective Prostate Artery Embolization for Treatment of Severe Haematuria Secondary to Rapid Progression of Treatment-Induced Neuroendocrine Prostate Cancer: A Case Report
BACKGROUND: Treatment-induced neuroendocrine prostate cancer (t-NEPC) represents a highly aggressive subtype of castration-resistant prostate cancer that commonly arises from prostate adenocarcinoma (AdPC) after continuous androgen deprivation therapy (ADT). However, current treatments for t-NEPC ar...
Autores principales: | Deng, Liang, Li, Chao, He, Qiangrong, Huang, Chenghui, Chen, Qian, Zhang, Shengwang, Wang, Long, Gan, Yu, Long, Zhi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8786387/ https://www.ncbi.nlm.nih.gov/pubmed/35082500 http://dx.doi.org/10.2147/OTT.S345193 |
Ejemplares similares
-
Loss of EHF facilitates the development of treatment-induced neuroendocrine prostate cancer
por: Long, Zhi, et al.
Publicado: (2021) -
Focus on the tumor microenvironment: A seedbed for neuroendocrine prostate cancer
por: Zhou, Hengfeng, et al.
Publicado: (2022) -
Immediate Transurethral Plasma Kinetic Enucleation of the Prostate Gland for Treatment of Benign Prostatic Hyperplasia-Associated Massive Hemorrhage: A Single-Center Experience
por: Gan, Yu, et al.
Publicado: (2022) -
Superselective Transcatheter Arterial Embolization in the Treatment
of Angiodysplasia
por: Leite, Túlio Fabiano de Oliveira, et al.
Publicado: (2019) -
A bibliometric study of the top 100 most-cited papers in neuroendocrine prostate cancer
por: Gan, Yu, et al.
Publicado: (2023)